Key result
Leadless pacemakers substantially reduce morbidity vs. transvenous devices, expanding indications in younger and excluded populations.
Why the study?
Leadless pacemaker indications have expanded to include younger and previously excluded populations, requiring an understanding of new applications to maximize benefits without compromising pacing quality.
Leadless pacemakers are increasingly used due to reduced morbidity compared to traditional transvenous devices, expanding their indications to broader patient populations.
Leadless pacemakers are being used with increased frequency due to improvements in the technologies, and the recognition of the substantial benefits over traditional transvenous devices. Current information shows a substantial reduction in morbidity with leadless devices which has resulted in a significant expansion in the indication for these devices. Patient selection now includes a younger population as well as those commonly excluded from consideration. Understanding these new applications will allow a larger group of patients to benefit from the significant advantages of leadless devices while not compromising quality and effective pacing. Further improvements in this technology will result in even more availability of these transformative devices.
No takes yet. Share an insight, caveat, or question.
Chinitz et al. (2025) conducted a review in Pacing indications. Leadless pacemakers vs. Traditional transvenous devices was evaluated. Leadless pacemakers provide a substantial reduction in morbidity compared to traditional transvenous devices, allowing for expanded indications in younger and previously excluded patient populations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: